Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$685.3M
-0.9% from 2023
Prescriptions
1.0M
$666.17 per claim
Patients
243K
130,692 prescribers
Total spending, 2024
$685.5M
$2,821.78 per patient
Medicare prescription drug plans paid $685.3M for Brilinta in 2024, for 1,028,780 prescriptions and refills to 242,862 patients (down 0.9% from 2023). The average cost per claim was $666.17.
California had the highest Medicare cost for Brilinta in 2024: $64.9M for 93,393 claims, followed by Florida ($59.9M).
Abdrhman Hamo, cardiology in Beckley, WV, had the highest Medicare cost for Brilinta in 2024: 695 claims costing $562K.
Brilinta is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Abdrhman Hamo Beckley, WV | Cardiology | 695 | 192 | $562K |
| James V Tran Westminster, CA | Internal Medicine | 499 | 92 | $377K |
| Wing Yi Liu New Smyrna Beach, FL |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 117,288 | 945,570 | 223,258 | $638.2M |
| 2023 | 124,439 | 980,557 | 234,659 | $691.5M |
| 2024 | 130,692 | 1,028,780 | 242,862 | $685.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 574 |
| 128 |
| $334K |
| Majed Nounou Lapeer, MI | Interventional Cardiology | 333 | 101 | $322K |
| Rudy M Haddad San Angelo, TX | Cardiology | 413 | 114 | $312K |
| Yili Huang Elmhurst, NY | Cardiology | 350 | 94 | $308K |
| Nicolaos G Abariotis Chicago, IL | Cardiology | 317 | 79 | $296K |
| Pridhvi R Yelamanchili Mesa, AZ | Interventional Cardiology | 324 | 105 | $288K |
| Ziad A Abbud Neptune, NJ | Interventional Cardiology | 299 | 95 | $270K |
| Hoang M Nguyen San Jose, CA | Cardiology | 344 | 74 | $269K |
| Michael L Krueger Fresno, CA | Cardiology | 315 | 90 | $240K |
| Saleem Husain Plainfield, NJ | Cardiology | 292 | 75 | $232K |
| Japhet G Joseph Bay City, MI | Cardiology | 306 | 90 | $227K |
| Henry C Yee Alhambra, CA | Cardiology | 404 | 67 | $226K |
| Arup Achari Houston, TX | Cardiology | 271 | 84 | $218K |
| Aung Min El Paso, TX | Cardiology | 211 | 75 | $215K |
| Muhammad F Jan Milwaukee, WI | Interventional Cardiology | 231 | 67 | $213K |
| Sinan H Sarsam Temecula, CA | Cardiology | 221 | 68 | $211K |
| Jaesoo Pak Cerritos, CA | Internal Medicine | 398 | 40 | $211K |
| Benoy Varghese Oklahoma City, OK | Cardiology | 289 | 68 | $211K |
| Larry C Chan Upland, CA | Cardiology | 419 | 88 | $210K |
| Zoheir A Abdelbaki Lima, OH | Cardiology | 240 | 65 | $207K |
| Rohit R Amin Pensacola, FL | Interventional Cardiology | 235 | 60 | $205K |
| Johnny R Dy Lenoir, NC | Cardiology | 296 | 73 | $202K |
| Hamid M Nia Hackensack, NJ | Cardiology | 306 | 87 | $199K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 1,029,007 | $685.5M |